The average one-year price target for GT Biopharma (NasdaqCM:GTBP) has been revised to 153.00 / share. This is an increase of 2,900.00% from the prior estimate of 5.10 dated January 16, 2024. The ...
The latest price target for GT Biopharma (NASDAQ:GTBP) was reported by Roth MKM on December 2, 2024. The analyst firm set a price target for $11.00 expecting GTBP to rise to within 12 months (a ...
Gain Therapeutics' GT-02287 shows promising efficacy and safety data, targeting both idiopathic and GBA1 Parkinson’s disease, with potential for substantial market impact and investor gains. The ...
TORONTO, April 17, 2019 (GLOBE NEWSWIRE) -- White Gold Corp. (TSX.V: WGO, OTC - Nasdaq Intl: WHGOF, FRA: 29W) (the "Company") is pleased to announce it has commenced its $13 million fully funded 2019 ...
[Carscoops] RS3 prototype spotted at Nürburgring, Germany with aggressive aero upgrades 2.5-liter five-cylinder turbo engine reaches its final evolution, targeting AMG A45-level performance Limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback